Healthcare provider profile · identity verified

Crystal Tina Sachdeva, M.D.

Internal Medicine · BRONX, NY · NPI 1477796431

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	683	217
Amlodipine Besylate	Amlodipine Besylate	428	126
Albuterol Sulfate Hfa	Albuterol Sulfate	347	70
Lisinopril	Lisinopril	316	78
Metformin Hcl	Metformin Hcl	259	64
Losartan Potassium	Losartan Potassium	213	61
Gabapentin	Gabapentin	191	62
Nifedipine Er	Nifedipine	188	48
Omeprazole	Omeprazole	174	45
Fluticasone Propionate	Fluticasone Propionate	155	56
Metoprolol Succinate	Metoprolol Succinate	154	40
Levothyroxine Sodium	Levothyroxine Sodium	145	34
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	142	48
Hydrochlorothiazide	Hydrochlorothiazide	142	44
Simvastatin	Simvastatin	135	42
Ammonium Lactate	Ammonium Lactate	123	40
Alendronate Sodium	Alendronate Sodium	120	42
Eliquis	Apixaban	120	22
Ozempic	Semaglutide	113	22
Meclizine Hcl	Meclizine Hcl	107	39
Januvia	Sitagliptin Phosphate	99	22
Naproxen	Naproxen	98	44
Jardiance	Empagliflozin	94	27
Famotidine	Famotidine	89	34
Ezetimibe	Ezetimibe	87	27
Rosuvastatin Calcium	Rosuvastatin Calcium	84	31
Metformin Hcl Er	Metformin Hcl	83	22
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	81	22
Tamsulosin Hcl	Tamsulosin Hcl	74	27
Furosemide	Furosemide	68	24
Diclofenac Sodium	Diclofenac Sodium	67	21
Pravastatin Sodium	Pravastatin Sodium	63	21
Pantoprazole Sodium	Pantoprazole Sodium	57	23
Novolog Flexpen	Insulin Aspart	55	11
Allopurinol	Allopurinol	53	15
Montelukast Sodium	Montelukast Sodium	53	17
Glipizide Er	Glipizide	52	17
Trazodone Hcl	Trazodone Hcl	52	12
Carvedilol	Carvedilol	51	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	49	suppressed
Chlorthalidone	Chlorthalidone	48	16
Ibuprofen	Ibuprofen	48	18
Alcohol Prep Pads	Alcohol Antiseptic Pads	47	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	13
Hydrocortisone	Hydrocortisone	44	suppressed
Lidocaine	Lidocaine	44	13
Meloxicam	Meloxicam	43	18
Clopidogrel	Clopidogrel Bisulfate	40	12
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	40	13
Farxiga	Dapagliflozin Propanediol	39	suppressed
Linzess	Linaclotide	38	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	13
Triamcinolone Acetonide	Triamcinolone Acetonide	38	21
Hydroxyzine Hcl	Hydroxyzine Hcl	37	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	36	suppressed
Ventolin Hfa	Albuterol Sulfate	36	11
Glimepiride	Glimepiride	35	suppressed
Valsartan	Valsartan	35	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	34	13
Shingrix	Varicella-Zoster Ge/As01b/Pf	34	32
Single Use Swab	Alcohol Antiseptic Pads	34	15
Atenolol	Atenolol	32	12
Finasteride	Finasteride	31	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	31	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	30	suppressed
Sertraline Hcl	Sertraline Hcl	30	suppressed
Oxycodone Hcl	Oxycodone Hcl	29	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Spironolactone	Spironolactone	27	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	27	suppressed
Epinephrine	Epinephrine	26	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	26	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	26	suppressed
Azelastine Hcl	Azelastine Hcl	25	suppressed
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Rizatriptan	Rizatriptan Benzoate	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	25	suppressed
Folic Acid	Folic Acid	24	suppressed
Clotrimazole	Clotrimazole	23	suppressed
Glipizide	Glipizide	23	suppressed
Irbesartan	Irbesartan	23	suppressed
Telmisartan	Telmisartan	23	suppressed
Baclofen	Baclofen	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Vascepa	Icosapent Ethyl	22	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	20	suppressed
Potassium Chloride	Potassium Chloride	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Tresiba Flextouch U-100	Insulin Degludec	20	suppressed
Enalapril Maleate	Enalapril Maleate	19	suppressed
Entresto	Sacubitril/Valsartan	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Lactulose	Lactulose	18	suppressed
Levemir Flexpen	Insulin Detemir	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Breyna	Budesonide/Formoterol Fumarate	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Crestor	Rosuvastatin Calcium	12	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Xulane	Norelgestromin/Ethin.Estradiol	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Methimazole	Methimazole	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
True Comfort Pro Alcohol Pads	Alcohol Antiseptic Pads	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error